Overview

A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.
Phase:
Phase 2
Details
Lead Sponsor:
SK Life Science
SK Life Science, Inc.